title: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
authors.forename: Bernard
authors.initials: B
authors.lastname: Zinman
authors.forename: John M
authors.initials: JM
authors.lastname: Lachin
authors.forename: Silvio E
authors.initials: SE
authors.lastname: Inzucchi
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005960:Glucosides / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents